Candoxatril
| Names | |
|---|---|
| Preferred IUPAC name
(1R,4s)-4-(1-{(2S)-3-[(2,3-Dihydro-1H-inden-5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl}cyclopentan-1-amido)cyclohexane-1-carboxylic acid | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| MeSH | candoxatril |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C29H41NO7 | |
| Molar mass | 515.647 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Candoxatril is the orally active prodrug of candoxatrilat (UK-73967).